Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Dextrothyroxine is a thyroid hormone used to treat hyperlipidemia. The major hormone derived from the thyroid gland.
- Mechanism
- Curator reviewed
Dextrothyroxine is a antihyperlipidemic. The mechanism of action is not completely understood, but dextrothyroxine apparently acts in the liver to stimulate formation of low-density lipoprotein (LDL) and, to a much greater extent, to increase catabolism of LDL. This leads to increased excretion of cholesterol and bile acids via the biliary route into the feces, with a resulting reduction in serum cholesterol and LDL. Dextrothyroxine has no significant effect on high-density lipoproteins (HDL). Inherently, it will also bind to thyroid receptors and as it is a prohormone, it will bind as a substrate to iodide peroxidase.
- Primary indication
- Used to lower high cholesterol levels in the blood.Curator reviewed
- Formula / weight
- C15H11I4NO4 · 776.87 g/mol (avg)
- First approval
- Canada, 1960
- Also known as
- D-thyroxine
Resolves to
XUIIKFGFIJCVMT-GFCCVEGCSA-NSMILESN[C@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=OWhat you can answer from here — as of September 12, 2026
Which drugs share a target with Dextrothyroxine, and which of those have an active Phase 3 trial?